ACTH responses to somatostatin, valproic acid and dexamethasone in Nelson's syndrome

Neuroendocrinology Letters

Volumn 26, Issue 6, 2005, Pages 709-712

  Kasperlik Załuska, Anna A ^a   Zgliczyński, Wojciech ^a   Jeske, Wojciech ^a   Zdunowski, Piotr ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

ACTH; Dexamethasone; Nelson's syndrome; Somatostatin; Valproic acid

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE; OCTREOTIDE; VALPROIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; CASE REPORT; CONCENTRATION (PARAMETERS); CORTICOTROPIN BLOOD LEVEL; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; HYPOPHYSIS TUMOR; IMMUNORADIOMETRIC ASSAY; NELSON SYNDROME;

EID: 33644996546     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cohen KL, Noth RH, Pechinski T. Incidence of pituitary tumours following adrenalectomy. Arch Intern Med 1978; 138:575-579.
2. Dornhorst A, Jenkins JS, Lamberts SWJ, Abraham RR, Wynn V, Beckford U, et al. The evaluation of sodium valproate in the treatment of Nelson's syndrome. J Clin Endocrinol Metab 1983; 56:985-991.
3. Hartwig W, Kasperlik-Załuska A, Wilczyńska J, Migdalska B. Cyproheptadine in pituitary disorders. N Engl J Med 1976; 295:394.
4. Hartwig W, Kasperlik-Załuska A, Wilczyńska J, Migdalska B, Czechowicz-Janicka K, Zaluska J. Cyproheptadine in the treatment of Nelson's syndrome. Endokrynol Pol 1979; 30:171-174.
5. Hodgkinson SC, Allolio B, Landon J, Lowry PJ. Development of non-extracted "two-site" immunoradiometric assay for corticotropin utilising extreme amino- and carboxylterminally directed antibodies. Biochem J 1984; 218:703-706.
6. Kasperlik-Załuska AA, Nielubowicz J, Wislawski J, Hartwig W, Zaluska J, Jeske W, Migdalska B. Nelson's syndrome: incidence and prognosis. Clin Endocrinol 1983; 19:693-698.
7. Kasperlik-Załuska A, Drac-Kaniewska J, Migdalska B, Jeske W, Wiśniewska-Woźniak T. The effect of sodium valproate on plasma ACTH and cortisol, concentrations in Cushing's disease and Nelson's syndrome. Endokrynol Pol 1988; 39:245-252.
8. Kasperlik-Załuska A, Migdalska B, Jeske W, Drac-Kaniewska J, Wiśniewska-Woźniak T. The effect of magnesium valproate on plasma ACTH concentrations in Nelson's syndrome. Acta Med Pol 1989; 30:9-15.
9. Kasperlik-Załuska A, Niegowska E, Migdalska B, Jeske W, Zieliński M. A correlative study between cortisol and ACTH in Cushing's disease following bilateral adrenalectomy and in Nelson's syndrome. Endokrynol Pol 1992; 43:314-321.
10. Kasperlik-Zaluska AA, Walecki J, Jeske W, Migdalska B, Janik J, Bonicki W. et al. Early diagnosis of Nelson's syndrome. J Mol Neurosci 1996; 7:87-90.
11. Kasperlik-Załuska AA, Jeske W. Management of Nelson's syndrome: observation in fifteen patients. Clin Endocrinol 2001; 55:819-822.
12. Kasperlik-Zaluska AA, Zgliczynski W, Jeske W, Janik J, Bonicki W. A new insight into the Nelson's syndrome. Abstract Book, 6th European Congress of Endocrinology; April 26-30, 2003; Lyon, France, P1126.
13. Kelly PA, Samandouras G, Grossman AB, Afshar F, Besser GM, Jenkins PJ. Neurosurgical treatment of Nelson's syndrome. J Clin Endocrinol Metab 2002; 87:5465-5469.
14. Kemink SAG, Smals AGH, Hermus ARMM, Pieters GFFM, Kloppenborg PWC. Nelson's syndrome: a review. Endocrinologist 1997; 7:5-9.
15. Kemink SAG, Grotenhuis JA, De Vries J, Pieters GFFM, Hermus ARMM, Smals AGH. Management of Nelson's syndrome: Observations in fifteen patients. Clin Endocrinol 2000; 54:45-52.
16. Krieger D, Luria M. Effectivness of cyproheptadine in decreasing plasma ACTH concentrations in Nelson's syndrome. N Engl J Med 1976; 43:1179-1182.
17. Lamberts S, Uitterlinden P. Klijn F. The effect of the long acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease. Acta Endocrinol 1989; 120:760-766.
18. Moore TJ, Dluhy RG, Williams GH, Cain JP. Nelson's syndrome: frequency, prognosis, and effect of prior pituitary irradiation. Ann Int Med 1976; 85:731-734.
19. Nelson DH, Meakin JW, Dealy JB, Matson DD, Emerson K Jr, Thorn GW. ACTH-producing tumor of the pituitary gland. N Eng] J Medl 958; 259:61-64.
20. Zgliczyński W, Zgliczyński S, Jeske W, Bonicki W, Podgórski J, Królicki L. The Somatostatin analog (SR-Lanreotide) pretreatment Improves surgical outcome in acromegalic patients harbouring pituitary tumours with somatostatin receptors. J Endocrinol Invest 1997; 20:45-47.